Mild Traumatic Brain Injury Contributes to the Development of Delayed Neuroinflammation

Neuroimmunomodulation. 2022;29(2):135-142. doi: 10.1159/000519011. Epub 2021 Sep 28.

Abstract

Introduction: In recent years, according to the literature, the problem of mild traumatic brain injury (mTBI) has become more and more urgent. Compared to moderate to severe craniocerebral trauma, mTBI occurs in a far greater number of people. The delayed sequelae caused by a single mTBI or multiple mTBIs are a significant public health problem.

Methods: A weight-drop model was used for the formation of mTBI. A metal rod weighing 337 g with a blunt tip of 3 mm diameter was uplifted at 8 cm height and held by a lever. The trauma was created by lowering the lever and the rod and free-dropping onto the rat skull. In the cerebral cortex of experimental animals, we analyzed the level of microglial activity (Iba-1-positive system) and the expression of pro-inflammatory markers (IL1β, IL6, and CD86). Also, the expression level of the endocannabinoid system receptor (cannabinoid receptor type 1 [CB1]) was assessed in brain samples.

Results: Experiments have shown that mTBI increases (1) the amount of microglia (iba-1) activated by the pro-inflammatory pathway (CD86); (2) the level of pro-inflammatory cytokines IL1β and IL6; and (3) CB1R activity.

Conclusion: Overall, the results of this study indicate that mTBI induces a sustained neuroinflammatory response.

Keywords: CD86; Cannabinoid receptor type 1; Endocannabinoid system; IL1β; IL6; Microglia; Mild traumatic brain injury.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism
  • Brain Concussion* / complications
  • Brain Concussion* / metabolism
  • Cytokines / metabolism
  • Humans
  • Microglia / metabolism
  • Neuroinflammatory Diseases
  • Rats

Substances

  • Cytokines